Company profile for Ipca Laboratories

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is ded...
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
Kandivli (West), Mumbai – 400 067, Maharashtra
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”
This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

Impressions: 4926

https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

Radio Compass
16 Dec 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch
Since 2022, there has been a significant surge in layoffs by pharmaceutical and biotech companies. While this trend continued into 2024, the industry showed signs of stabilization in the last four months of the year with the pace of layoffs slowing down. Nonetheless, 2024 was a challenging year. Data compiled by PharmaCompass indicates that over 25,000 layoffs were announced in 2024, driven by economic pressures, failed clinical trials, and strategic pivots. Bristol Myers Squibb and Johnson & Johnson led the layoffs with about 2,300 job cuts each. Bayer announced elimination of 1,800 positions.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available) US, Europe, China bear brunt of job cuts; Big Pharma hands pink slips to 10,000 Over 190 biopharma companies announced layoffs in 2024. The year began on a grim note — 27 firms announced significant job cuts in January 2024. By the yearend, Big Pharma alone had contributed more than 10,000 layoffs to the year’s total of over 25,000. Novartis announced over 1,200 job cuts in 2024. It eliminated 330 jobs after it acquired German biotech MorphoSys through the closure of sites in Munich and Boston. Similarly, Bayer announced significant reductions at its US and Swiss facilities.  North America saw increased retrenchments, especially at biotech hubs such as Boston, San Diego, and New Jersey. Massachusetts, with Boston and Cambridge as the epicenter of US biotechnology, saw around 4,000 layoffs, with companies like Relay Therapeutics, Editas Medicine, and Takeda driving the numbers. In San Diego, workforce reductions by Takeda, and Bavarian Nordic collectively resulted in over 900 job losses, significantly impacting the local biotech ecosystem. New Jersey was subject to broader restructuring efforts with BMS and Bayer contributing nearly 1,500 layoffs. The impact in Europe was equally severe. Germany, home to some of the world’s largest pharmaceutical companies, saw over 2,500 layoffs as Bayer and Boehringer Ingelheim scaled back operations. Novartis’ decision to shut down its Munich site added hundreds more to the tally. In Switzerland, Idorsia eliminated 270 positions. Dutch biotech UniQure reduced its workforce by 65 percent (around 300 jobs). That included the sale of a Massachusetts manufacturing facility to Genezen. Denmark also felt the strain, with Leo Pharma cutting 250 roles as part of a strategic revamp. China emerged as another focal point of workforce reductions in 2024. Global pharmaceutical giants, such as Merck and Johnson & Johnson, restructured their operations in response to market complexities in the region. Local companies such as Connect Biopharma, which is transitioning to a US-focused company, also scaled back their presence in the country.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Amylyx, FibroGen, Lyra, Athira drastically reduce staff over setbacks in clinical trials Clinical trial failures were one of the most significant drivers of layoffs in 2024. For instance, Amylyx Pharmaceuticals faced a devastating blow when its amyotrophic lateral sclerosis (ALS) therapy, Relyvrio, failed a confirmatory trial. This led to a 70 percent reduction in its workforce, leaving only 100 employees from the 384 full-time staff reported at the end of 2023. The company’s decision to pull the therapy from the market compounded the layoffs. BioMarin Pharmaceutical had to reduce its workforce, as it streamlined its pipeline in response to trial challenges. In August, the company announced a reduction of 225 employees, citing “organizational redesign efforts”. These layoffs followed 170 redundancies announced earlier in May. FibroGen, once considered a leader in oncology drug development, was among the most heavily impacted. The high-profile failure of its anti-CTGF antibody in two late-stage cancer trials led to the discontinuation of its lead candidate, resulting in a 75 percent reduction in its US workforce. Lyra Therapeutics also implemented a 75 percent workforce reduction, affecting 87 employees, after its chronic rhinosinusitis program struggled. Similarly, Athira Pharma cut 70 percent of its team after its Alzheimer’s candidate failed a phase 2/3 trial.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Cash crunch, mergers compel Kronos Bio, Editas, Vincerx, Gilead to downsize In addition to clinical failures, funding constraints played a pivotal role in reshaping the biotech landscape. Kronos Bio stood out as one of the hardest-hit firms, cutting 21 percent and 83 percent of its existing workforce in March and November, respectively, as it sought to divest assets and conserve cash. Editas Medicine’s inability to secure partnerships for its sickle cell program forced the company to revert to preclinical research, resulting in a 65 percent workforce reduction. The trend of scaling back R&D pipelines was particularly evident among biotechs struggling to advance preclinical programs to clinical trials. Boundless Bio and Senti Bio exemplified this, choosing to focus on a handful of promising candidates, while reducing discovery efforts. Consolidation often results in overlapping roles, leading to inevitable workforce reductions. Apart from the MorphoSys layoffs by Novartis, Vincerx Pharma faced job losses after it got acquired by Oqory (a clinical-stage ADC company). Vincerx had to cut its workforce by 55 percent.  Amid ongoing reorganization efforts, Gilead closed its Seattle, Washington (US), office and laid off 72 employees of its subsidiary Kite Pharma. Gilead also announced that its Kite facility in Philadelphia, Pennsylvania (US), would close by mid-2025. That was followed by 104 additional layoffs at its California headquarters. In April, it had cut 58 jobs in California. Gilead also announced that its Kite facility in Philadelphia would close by mid-2025. Vir Biotechnology reduced its workforce by 25 percent (i.e. 140 layoffs) to focus on its hepatitis program, and GlycoMimetics let go of 80 percent of its workforce after the FDA demanded an additional clinical trial for its leukemia treatment. Meanwhile, Lexicon Pharmaceuticals reduced its workforce by 60 percent after it stopped commercial operations and transitioned back to being a clinical stage company.  View Our Interactive Dashboard on Biopharma Layoffs in 2024 (Free Excel Available)  Our view It takes decades to build innovation ecosystems. The concentration of layoffs in major biotech hubs has raised concerns about the potential long-term impact on these ecosystems. In 2025, the key challenge will be to maintain the momentum of innovation, as organizations operate with a leaner workforce and a more focused pipeline.  

Impressions: 4652

https://www.pharmacompass.com/radio-compass-blog/bms-j-j-bayer-lead-25-000-pharma-layoffs-in-2024-amylyx-fibrogen-kronos-bio-hit-by-trial-failures-cash-crunch

#PharmaFlow by PHARMACOMPASS
16 Jan 2025

NEWS #PharmaBuzz

read-more
read-more

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ipca-labs-expects-its-us-generics-sales-to-touch-200-million-soon/articleshow/112662992.cms

ECONOMICTIMES
21 Aug 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205448

FDA
01 Aug 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205104

FDA
26 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206387

FDA
04 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204626

FDA
06 May 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204729

FDA
01 May 2024

01

Alendronate Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Alendronate Sodium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

02

Furosemide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Furosemide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

03

Glimepiride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Glimepiride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

04

Hydrochlorothiazide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Hydrochlorothiazide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

05

Metoprolol Tartrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Metoprolol Tartrate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

06

Propranolol Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Propranolol Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

07

Atenolol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Atenolol

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

08

Losartan Potassium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Losartan Potassium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WCarrow-down NDC KDMF arrow-down VMF Others AUDIT
blank

09

Chlorthalidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Chlorthalidone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

10

Hydroxychloroquine Sulphate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Hydroxychloroquine Sulphate

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

02

Duphat
Not Confirmed
arrow

08

Duphat
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more

01

Allopurinol

CEP/COS

Duphat
Not Confirmed
arrow

04

Atenolol

CEP/COS

Duphat
Not Confirmed
arrow

05

Atovaquone

CEP/COS

Duphat
Not Confirmed
arrow

08

Carvedilol

CEP/COS

Duphat
Not Confirmed
arrow

09

Celecoxib

CEP/COS

Duphat
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 218MF10276

Registrant's Address : 48, Kandivli Industrial Estate. Kandivli (W), Mumbai 400 067 India

Initial Date of Registration : 2006-02-23

Latest Date of Registration : 2007-01-22

blank

02

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 219MF10310

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India

Initial Date of Registration : 2007-10-05

Latest Date of Registration : 2022-07-27

blank

03

Atenolol

JDMF

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 218MF10439

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

Initial Date of Registration : 2006-04-27

Latest Date of Registration : 2024-02-07

blank

04

BENZARONE

JDMF

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 218MF10840

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India

Initial Date of Registration : 2006-10-20

Latest Date of Registration : 2006-10-20

blank

05

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 218MF10913

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India

Initial Date of Registration : 2006-11-10

Latest Date of Registration : 2013-04-05

blank

06

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 218MF10736

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India

Initial Date of Registration : 2006-09-06

Latest Date of Registration : 2010-09-03

blank

07

Furosemide

JDMF

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 225MF10191

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

Initial Date of Registration : 2013-10-09

Latest Date of Registration : 2013-10-09

blank

08

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 226MF10075

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

Initial Date of Registration : 2014-04-02

Latest Date of Registration : 2018-03-22

blank

09

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 224MF10171

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

Initial Date of Registration : 2012-08-16

Latest Date of Registration : 2021-09-02

blank

10

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Ipca Laboratories

Registration Number : 222MF10266

Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

Initial Date of Registration : 2010-12-08

Latest Date of Registration : 2010-12-08

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

LISTED APIs

read-more
read-more
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

01

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

02

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

03

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

04

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

05

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

06

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

07

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

08

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

09

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs....
Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.
blank

10

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical la...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Ipca Laboratories and get a quotation

Ipca Laboratories is a supplier offers 151 products (APIs, Excipients or Intermediates).

Find a price of Alendronate Sodium bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Furosemide bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Glimepiride bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Hydrochlorothiazide bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Metoprolol Tartrate bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Propranolol Hydrochloride bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Atenolol bulk with CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Losartan Potassium bulk with CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Allopurinol bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Amlodipine Besylate bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Carvedilol bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Chloroquine Phosphate bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Chlorthalidone bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Famotidine bulk with CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Hydroxychloroquine Sulphate bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Hydroxyzine Dihydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Indapamide bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Metformin bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Metoclopramide Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Nifedipine bulk with CEP, JDMF, WC offered by Ipca Laboratories

Find a price of Ondansetron Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Primaquine Diphosphate bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Proguanil bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Pyrantel Pamoate bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Pyrimethamine bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Quetiapine Hemifumarate bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Telmisartan bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Torsemide bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Trimethoprim bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Warfarin Sodium bulk with DMF, CEP, WC offered by Ipca Laboratories

Find a price of Bendroflumethiazide bulk with CEP, WC offered by Ipca Laboratories

Find a price of Bisoprolol Fumarate bulk with CEP, WC offered by Ipca Laboratories

Find a price of Citalopram Hydrobromide bulk with CEP, WC offered by Ipca Laboratories

Find a price of Etodolac bulk with CEP, WC offered by Ipca Laboratories

Find a price of Fenofibrate bulk with CEP, WC offered by Ipca Laboratories

Find a price of Fluconazole bulk with CEP, WC offered by Ipca Laboratories

Find a price of Flumequine bulk with CEP, WC offered by Ipca Laboratories

Find a price of Losartan Potassium bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Mesalazine bulk with CEP, WC offered by Ipca Laboratories

Find a price of Methylphenidate Hydrochloride bulk with CEP, WC offered by Ipca Laboratories

Find a price of Metoprolol Succinate bulk with CEP, WC offered by Ipca Laboratories

Find a price of Nabumetone bulk with CEP, WC offered by Ipca Laboratories

Find a price of Paroxetine Hydrochloride bulk with CEP, WC offered by Ipca Laboratories

Find a price of Valsartan bulk with CEP, WC offered by Ipca Laboratories

Find a price of Atovaquone bulk with CEP, WC offered by Ipca Laboratories

Find a price of Chlorthalidone bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Hydrochlorothiazide bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Lamotrigine bulk with CEP, WC offered by Ipca Laboratories

Find a price of Mesalazine bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Metoclopramide bulk with JDMF, WC offered by Ipca Laboratories

Find a price of Midodrine bulk with DMF, WC offered by Ipca Laboratories

Find a price of Olanzapine bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Ondansetron bulk with DMF, WC offered by Ipca Laboratories

Find a price of Promethazine Hydrochloride bulk with DMF, WC offered by Ipca Laboratories

Find a price of Risperidone bulk with DMF, WC offered by Ipca Laboratories

Find a price of Tramadol Hydrochloride bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Triamterene bulk with DMF, CEP offered by Ipca Laboratories

Find a price of Amodiaquine Hydrochloride bulk with WC offered by Ipca Laboratories

Find a price of Artemether bulk with WC offered by Ipca Laboratories

Find a price of Artesunate bulk with WC offered by Ipca Laboratories

Find a price of Atenolol bulk with DMF offered by Ipca Laboratories

Find a price of Benzarone bulk with JDMF offered by Ipca Laboratories

Find a price of Benzbromarone bulk with JDMF offered by Ipca Laboratories

Find a price of Cilostazol bulk with WC offered by Ipca Laboratories

Find a price of Clopidogrel bulk with WC offered by Ipca Laboratories

Find a price of Famotidine bulk with CEP offered by Ipca Laboratories

Find a price of Lumefantrine bulk with WC offered by Ipca Laboratories

Find a price of Metformin bulk with DMF offered by Ipca Laboratories

Find a price of Risedronate Sodium bulk with WC offered by Ipca Laboratories

Find a price of Sulfadoxine bulk with WC offered by Ipca Laboratories

Find a price of Warfarin Sodium bulk with CEP offered by Ipca Laboratories

Find a price of Zaltoprofen bulk with JDMF offered by Ipca Laboratories

Find a price of Zoledronic Acid bulk with JDMF offered by Ipca Laboratories

Find a price of Amlodipine Besylate bulk with CEP offered by Ipca Laboratories

Find a price of Amylmetacresol bulk with WC offered by Ipca Laboratories

Find a price of Bisoprolol Fumarate bulk with DMF offered by Ipca Laboratories

Find a price of Bupropion Hydrochloride bulk with DMF offered by Ipca Laboratories

Find a price of Celecoxib bulk with CEP offered by Ipca Laboratories

Find a price of Cetirizine Dihydrochloride bulk with DMF offered by Ipca Laboratories

Find a price of Dichlorobenzyl Alcohol bulk with WC offered by Ipca Laboratories

Find a price of Donepezil bulk with CEP offered by Ipca Laboratories

Find a price of Entacapone bulk with CEP offered by Ipca Laboratories

Find a price of Etodolac bulk with DMF offered by Ipca Laboratories

Find a price of Furosemide bulk with JDMF offered by Ipca Laboratories

Find a price of Hydrochlorothiazide bulk with CEP offered by Ipca Laboratories

Find a price of Isotretinoin bulk offered by Ipca Laboratories

Find a price of Levetiracetam bulk with CEP offered by Ipca Laboratories

Find a price of Levofloxacin bulk with WC offered by Ipca Laboratories

Find a price of Losartan Potassium bulk offered by Ipca Laboratories

Find a price of Meloxicam bulk with CEP offered by Ipca Laboratories

Find a price of Metoprolol Succinate bulk with DMF offered by Ipca Laboratories

Find a price of Metoprolol Tartrate bulk with DMF offered by Ipca Laboratories

Find a price of Morantel Tartrate bulk with WC offered by Ipca Laboratories

Find a price of Pantoprazole Sodium bulk offered by Ipca Laboratories

Find a price of Pentoxifylline bulk offered by Ipca Laboratories

Find a price of Perindopril Erbumine bulk offered by Ipca Laboratories

Find a price of Probenecid bulk with DMF offered by Ipca Laboratories

Find a price of Quetiapine Hemifumarate bulk with CEP offered by Ipca Laboratories

Find a price of Ractopamine Hydrochloride bulk with WC offered by Ipca Laboratories

Find a price of Risedronate Sodium bulk with DMF offered by Ipca Laboratories

Find a price of Tramadol Hydrochloride bulk offered by Ipca Laboratories

Find a price of Trazodone Hydrochloride bulk with CEP offered by Ipca Laboratories

Find a price of Triclabendazole bulk with WC offered by Ipca Laboratories

Find a price of Trimethoprim bulk with DMF offered by Ipca Laboratories

Find a price of Valsartan bulk with DMF offered by Ipca Laboratories

Find a price of Zopiclone bulk with WC offered by Ipca Laboratories

Find a price of DULOXETINE HYDROCHLORIDE USP bulk with DMF offered by Ipca Laboratories

Find a price of Alendronate Sodium bulk offered by Ipca Laboratories

Find a price of Allopurinol bulk offered by Ipca Laboratories

Find a price of Balsalazide Disodium bulk offered by Ipca Laboratories

Find a price of Clopidogrel bulk offered by Ipca Laboratories

Find a price of Erythromycin Estolate bulk offered by Ipca Laboratories

Find a price of Escitalopram Oxalate bulk offered by Ipca Laboratories

Find a price of Estradiol Valerate bulk offered by Ipca Laboratories

Find a price of Fluconazole bulk offered by Ipca Laboratories

Find a price of Flumequine bulk offered by Ipca Laboratories

Find a price of Lisinopril bulk offered by Ipca Laboratories

Find a price of Mesalazine bulk offered by Ipca Laboratories

Find a price of Nabumetone bulk offered by Ipca Laboratories

Find a price of Nifedipine bulk offered by Ipca Laboratories

Find a price of Norethisterone bulk offered by Ipca Laboratories

Find a price of Norethisterone Acetate bulk offered by Ipca Laboratories

Find a price of Pyrantel Pamoate bulk offered by Ipca Laboratories

Find a price of Pyrantel Tartrate bulk offered by Ipca Laboratories

Find a price of Ritalinic Acid bulk offered by Ipca Laboratories

Find a price of Testosterone bulk offered by Ipca Laboratories

Find a price of Testosterone Propionate bulk offered by Ipca Laboratories

Find a price of Testosterone Undecanoate bulk offered by Ipca Laboratories

Find a price of Tibolone bulk offered by Ipca Laboratories

Find a price of Triclosan bulk offered by Ipca Laboratories

Find a price of Zolpidem Tartrate bulk offered by Ipca Laboratories

Find a price of FACILITY FOR BULK DRUG PRODUCTION IN INDORE INDIA bulk offered by Ipca Laboratories

Find a price of FACILITY IBD-D IN PIN., INDIA bulk offered by Ipca Laboratories

Find a price of IBD-IV MANUFACTURING FACILITY IN RATLAM, INDIA bulk offered by Ipca Laboratories

Find a price of Arteether bulk offered by Ipca Laboratories

Find a price of Cetirizine bulk offered by Ipca Laboratories

Find a price of Citalopram bulk offered by Ipca Laboratories

Find a price of Estradiol bulk offered by Ipca Laboratories

Find a price of Nandrolone Phenpropionate bulk offered by Ipca Laboratories

Find a price of Phenylephrine Hydrochloride bulk offered by Ipca Laboratories

Find a price of Piperaquine Phosphate bulk offered by Ipca Laboratories

Find a price of Serratiopeptidase bulk offered by Ipca Laboratories

Find a price of Silodosin bulk offered by Ipca Laboratories

Find a price of Simvastatin bulk offered by Ipca Laboratories

Find a price of Sumatriptan bulk offered by Ipca Laboratories

Find a price of Testosterone Cypionate bulk offered by Ipca Laboratories

Find a price of Testosterone Decanoate bulk offered by Ipca Laboratories

Find a price of Testosterone Isocaproate bulk offered by Ipca Laboratories

Find a price of Testosterone Phenylpropionate bulk offered by Ipca Laboratories

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty